3D body scanning platform Bodd has raised $15 million as it looks to expand globally.
The round was led by US strategic investor Blue Sky Capital, supported by Ellerston Capital. Existing investors, including chairman Tim Allison, director Peter Leonard, Swans director John Gerahty and his family office Liangrove Group, commodities trader Ken Loughnan and fashion retailers Nick and Candice Hirons also chipped in.
The raise had an initial target of $10 million, but increased by 50% due to investor demand, increasing Bodd’s valuation to $110 million.
The capital is for expansion into the US, where they’ll open an office, as well as the UK and Middle East, plus increasing the headcount to 40, up from 15 when Bodd last raised $5 million in early 2023.
Bodd’s customers include United Airlines and Brooks Brothers in North America and workwear manufacturer Portwest in Dublin, as well as Australian Defence Apparel, the New Zealand Defence Force, and uniform manufacturer Stewart & Heaton.
Bodd began life in 2016, as a clothing tech startup cofounded by Rob Fisher and David McLaughlin. Its 3D body scanning technology collects the data needed for clothing fittings – dubbed a body “passport” – in just 60 seconds, reduce sizing times for organisations with large workforce uniform or equipment requirements.
Now the business is turning its attention to healthtech, with plans to deploy in Australian pharmacies in 2026 to capturing data on the human body and support growing demand for GLP-1 (weight loss) treatments.
Fisher, Bodd’s CEO, said the investor demand backed their thesis that the body data industry needs innovation, with a focus on defence, aviation and healthcare.
“It validates the hard work the Bodd team continues to invest in our products and customers. With AI rapidly reshaping how organisations make decisions, the need for high quality data has only become increasingly important,” he said.
“Bodd’s high-fidelity data bridges this gap and enables AI models to be trained and applied with far greater precision for real-world use cases.”
Blue Sky Capital’s Steve Bellotti said the possibilities for use of the startup’s data is almost infinite.
“Bodd’s high-fidelity body scans have enormous propensity to drive global efficiencies at both a precise and population level,” he said.
“We see strong alignment with where the industry is heading and the data that Bodd can produce.”
Bodd’s product also helped correctly fit tailored suits for AFL players Mason Cox and Max Gawn, among others.



Daily startup news and insights, delivered to your inbox.